KNSA vs MGM · P/E 53, rev $677.6M vs P/E 64, rev $4.45B
Kiniksa Pharmaceuticals Ltd (KNSA) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the KNSA and MGM stock pages for the full models.
Not investment advice.